News > i3

Digital Health Tech Expo

CTA brought together members of the consumer technology, medical and regulatory communities at the U.S. Food and Drug Administration (FDA) for a day-long Digital Health Technology Expo on September 26, to explore the future of technology in healthcare.

About 450 FDA employees, CTA Health & Fitness Tech members and invited guests attended the panels and exhibits, including FDA Commissioner Robert Califf.

In addition, 16 CTA member companies demonstrated their health-related technologies for FDA staff including Adidas, Fitbit, Qualcomm Life, Samsung, Sony, Under Armour, Validic and Valencell. CTA President and CEO Gary Shapiro gave the keynote address and Associate Director of Digital Health, FDA’s Center for Devices and Radiological Health Bakul Patel gave opening remarks.

“Events such as CTA’s Digital Health Technology Expo allow the public and private sectors to share critical information about health and fitness technology that empowers consumers, reduces costs and improves outcomes to change our lives for the better,” said Shapiro. “The FDA’s recent work has helped create an environment that fosters tech innovations in healthcare. We are pleased to partner with the agency, so these stakeholders can have the meaningful discussions we need to ensure technology continues to advance the healthcare sector.”

The event included presentations from CTA, the FDA, and the U.S. Department of Health and Human Services, as well as government, academic and industry market leaders on consumer technology’s role in advancing healthcare. Innovations in biometric wearables for healthcare data delivery; ways innovators and regulators can work together to drive innovation in healthcare technology; and how patient enerated data can create positive change by enabling patients and caregivers to drive positive behavior change and reduce health risks, was discussed.

“FDA staff had the chance to discuss and learn more about the future of consumer technology in healthcare, including how regulators and industry can prepare for the ever-changing landscape in digital health. At the FDA, we are committed to working with all of our stakeholders to promote innovation and protect patient safety,” said Patel.

Julie Kearney, Vice President, Regulatory Affairs, CTA